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Previous studies mapped a p2 domain (aa 82–109) which binds phosphatidylserine (PS) (Estepa and Coll, 1996a) and
contains three contiguous hydrophobic amino acid heptad repeats followed by a positively charged stretch (Coll, 1995b) in
the glycoprotein G of the viral hemorrhagic septicemia virus (VHSV), a fish rhabdovirus. Anti-p2 antibodies inhibited low-pH
VHSV-induced fusion (Estepa and Coll, 1997) and low-pH PS binding to VHSV (Estepa and Coll, 1996a). We report here further
studies on the interaction of the synthetic peptide p2 with phospholipid vesicles. The synthetic p2 peptide was able to
mediate aggregation, lipid mixing, and leakage of contents only with negatively charged phospholipid vesicles and in a
concentration-dependent manner. As shown by its effect on lipid phase transitions deduced from data with fluorescence
polarization and differential scanning calorimetry, the p2 peptide becomes inserted into the hydrophobic negatively charged
phospholipid vesicle bilayers. In addition, data based on circular dichroism showed that the p2 peptide folds as a structure
with a high content of b-sheets stabilized by interaction with anionic phospholipids. These studies are potentially relevant to
viral fusion in VHSV. © 1998 Academic Press
INTRODUCTION
The fusion of the membrane of enveloped viruses with
the membrane of their target cells is one of the first steps
of the viral infection cycle (Hernandez et al., 1996). Only
after the fusion of the viral and cellular membranes can
the viral nucleocapsid enter the cytoplasm to continue its
infective events (White, 1990, 1992). The unique glyco-
protein G is responsible for the binding to cellular mem-
branes and for the subsequent low-pH (pH 5–6) depen-
dent fusion with them (Rigaut et al., 1991; Schlegel et al.,
1982; Superti et al., 1984), both in mammalian (Gaudin et
al., 1993, 1992) and in fish (Estepa and Coll, 1996a;
Lecocq-Xhonneux et al., 1994) rhabdoviruses. Glycopro-
tein G of rhabdoviruses interacts with the phospholipid
components of the cellular membranes (Gaudin et al.,
1992; Lenard, 1993). Furthermore, phospholipids inhib-
ited binding and infection of rabies (Superti et al., 1984)
and of vesicular stomatitis virus (VSV) (Bailey et al., 1984;
Conti et al., 1988; Mastromarino et al., 1987). Moreover,
inhibition of VSV attachment and infection by phosphati-
dylserine (PS) (Schlegel et al., 1982) and binding of PS by
viral hemorrhagic septicemia (VHS) rhabdovirus (Estepa
and Coll, 1996b) have also been reported.
PS binding to solid-phase 15-mer peptides (pepscan)
mapped the major PS-binding domain of glycoprotein G
of the viral hemorrhagic septicemia virus (VHSV) to the
region of aa 82–109 (p2) (Coll, 1997; Estepa and Coll,
1996a,b). That the PS binding to p2 in solid phase could
be relevant to the infective cycle of VHSV (Coll, 1996) was
supported by the capacity of anti-p2 polyclonal antibod-
ies to recognize both p2 and VHSV only at the low pH
required for viral fusion (Estepa and Coll, 1996b), to
inhibit PS binding to VHSV in solution only at low pH
(Estepa and Coll, 1996a), and to inhibit low-pH VHSV-
induced cell to cell fusion (Estepa and Coll, 1997). Fur-
thermore, similar pH-dependence profiles were shown
by PS binding to purified VHSV (Estepa and Coll, 1996a)
and by glycoprotein G-mediated cell to cell membrane
fusion (Lecocq-Xhonneux et al., 1994). The PS-binding
peptide sequence (p2) of glycoprotein G of VHSV con-
tained three contiguous a–d hydrophobic heptad repeats
followed by a charged head with two arginines (Coll,
1995a,b). The p2 sequence was totally conserved in two
published (Lorenzen et al., 1993; Thiry et al., 1991a) and
in seven other unpublished (A. Benmansour, personal
communication) sequences of glycoprotein G from VHSV
(Coll, 1997). On the other hand, p2-like regions were
present in all rhabdoviruses (Coll, 1995b), synthetic pep-
tides derived from them also bound PS (Coll, 1997), and
the mapping of VSV fusion-defective mutants and of VSV
and rabies virus hydrophobic photolabeled regions (Gau-
din et al., 1995a; Li et al., 1993; Powers et al., 1991; Whitt
et al., 1990) were located near to the p2-like regions (Coll,
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1995b). All the above-mentioned results suggest that
both p2-like regions and fusion might be functionally
related in all rhabdoviruses.
The ability of synthetic peptides corresponding to se-
quences potentially involved in fusion to penetrate into
membranes and to destabilize them, as well as the
requirements of peptide structure for this function, might
be adequate models that can reveal some of the molec-
ular mechanisms of the fusion mediated by viral fusion
proteins. Similar approaches in other viral glycoproteins
have already been reported (Duzgunes and Shavnin,
1992). Thus, a synthetic peptide from glycoprotein G of
the rhabdovirus causing VHS, a significant disease in
European salmonid farms, comprising the above-men-
tioned p2 sequence (Estepa and Coll, 1996b) has been
used in this work to study its interaction with phospho-
lipids by employing a variety of biophysical assays. The
results are discussed in terms of the possible interaction
of this sequence with the target cellular membrane dur-
ing the initial rhabdoviral infective steps.
RESULTS
Membrane destabilization induced by the p2 peptide
Figure 1 shows the changes in the absorbance at 360
nm after mixing PS vesicles with the p2 peptide at vari-
ous phospholipid/peptide ratios. Since isolated PS or p2
had no adsorbing species at 360 nm, the apparent ab-
sorbance values that appear when p2 is added to the PS
vesicles should be due to the scattered light produced by
the p2-induced aggregation or increase in size of PS
vesicles. At neutral pH the peptide interacts with PS,
although to a lower extent than at acidic pH. In the
presence of PC the increase in absorbance was almost
negligible even at acidic pH, indicating the specificity of
the observed peptide–phospholipid interaction in solu-
tion.
The p2 peptide was also able to induce membrane
phospholipid mixing between the NBD-PE/RH-PE fluo-
rescent probes containing PS vesicles (labeled) and the
fluorescent probe-free PS vesicles (unlabeled). Figure 2
shows that the final extent of phospholipid mixing was
dependent on the peptide concentration and was slightly
higher at acidic pH. The fact that the observed change in
energy transfer represents a decrease in the acceptor
surface density of approximately 7- to 10-fold (from 74 to
16% at pH 7.0 and from 74 to 10% at pH 5.0) would
indicate that the p2 peptide has induced a complete
fusion between the labeled and unlabeled vesicles. The
mere aggregation of vesicles would not result in such a
change in energy transfer (Blumenthal et al., 1983). More-
over, this assay of phospholipid mixing has been taken
as a reliable indicator of membrane fusion (Duzgunes et
al., 1987).
The ability of the peptide to destabilize lipid bilayers
was further assessed by measuring the p2-induced leak-
age of the intravesicular aqueous content from phospho-
lipid vesicles. Vesicle aqueous content leakage was
monitored by the dilution of coencapsulated ANTS and
DPX that leads to a rapid increase in the ANTS fluores-
cence at 520 nm (Ellens et al., 1985). Figure 3 shows the
aqueous content leakage induced by the p2 peptide
FIG. 2. Lipid mixing induced by the p2 peptide. The p2 peptide
dissolved in DMSO (5 mg/ml) was added to 0.14 mM of PS vesicles in
medium buffer at the appropriate pH and the mixture incubated for 1 h
at 37°C. (E) pH 7.0; (F) pH 5.0; (*), DMSO alone. The energy transfer
between NBD-PE and RH-PE was calculated as indicated under Meth-
ods. The results shown are representative of those obtained for three
different experiments.
FIG. 1. Changes in the absorbance at 360 nm induced by the
interaction of the p2 peptide with phospholipid vesicles. To 1 ml of
vesicles (0.14 mM) of PS or PC in medium buffer at the appropriate pH,
aliquots of peptide p2 from a 5 mg/ml stock solution in DMSO were
added. (E) PS at pH 7.0; (F) PS at pH 5.0; () PC at pH 5.0; (*), DMSO
alone at the concentration corresponding to the highest p2 concentra-
tion used. The absorbance was measured after incubating the sample
for 1 h at 37°C. The results shown are representative of those obtained
for three different experiments.
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added to a PS vesicle suspension. At the two pH values
tested, the peptide was able to induce a rapid release of
the internal content of the vesicles in a concentration-
dependent manner. Under the conditions employed in
this assay no differences were found at the two pH
values tested. Also, the maximum effect on vesicle aque-
ous content leakage was reached at a slightly lower
peptide concentration than that needed to induce maxi-
mum aggregation or lipid mixing.
The results shown in Figs. 1–3 were obtained upon
interaction at 37°C. Nevertheless, similar results were
obtained after incubation at 20°C in the three assays.
Studies of peptide insertion into phospholipid bilayers
The fact that the p2 peptide does not induce aggrega-
tion of neutral phospholipids (Fig. 1) indicates the impor-
tance of electrostatic interactions in eliciting the ob-
served vesicle destabilization effects but gives no infor-
mation on the possible relevance of hydrophobic
interactions in the association of the peptide with the
vesicles. To explore such possibility we choose to use
DMPG vesicles because this synthetic phospholipid has
a convenient transition temperature of 23.3°C. Thus, the
possible effect of increasing temperatures on the pep-
tide conformation is minimized compared to what it
would have been in the case of DMPS, which has a
transition temperature of 37°C.
The interaction of the p2 peptide with phospholipid
vesicles has a great effect on the thermotropic behavior
of DMPG vesicles. Figure 4 shows the fluorescence
polarization of DPH-labeled DMPG vesicles in the pres-
ence of p2 peptide at a phospholipid to peptide molar
ratio of 7.5 to 1. The main transition temperature for the
pure phospholipid is observed at 23–24°C, while the
addition of the p2 peptide completely abolished the tran-
sition at both pH 7.0 and 5.0. The behavior observed is
that of an integral molecule which strongly restricts the
mobility of the phospholipid acyl chains, suggesting the
insertion of the peptide into the membrane.
The possible insertion of the p2 peptide in the mem-
brane was also assessed by differential scanning calo-
rimetry (DSC). DSC was only performed at pH 5.0 due to
the high amounts of peptide that this technique demands
and the availability of the peptide. Figure 5 shows that
the p2 peptide causes a concentration-dependent de-
crease in the transition enthalpy without modifying the
phase transition temperature. At a peptide/DMPG molar
ratio of 0.1 the transition is completely inhibited. This
inhibition indicates that the p2 peptide becomes inserted
into the lipid bilayer, interacting hydrophobically with the
phospholipid acyl chains, preventing part of the phos-
pholipid molecules from undergoing the phase transition
characteristics of the ‘‘pure’’ phospholipid species (Papa-
hadjopoulos et al., 1975).
A plot of the observed changes in the transition en-
thalpies versus the peptide/phospholipid molar ratios
used in these studies (insert of Fig. 5) predicts that each
FIG. 4. Temperature dependence of fluorescence polarization of
DPH-labeled DMPG vesicles. Phospholipid vesicles were labeled with
DPH and fluorescence polarization was measured at the indicated
temperature. The phospholipid concentration was 0.14 mM and the
DPH probe to lipid molar ratio was 1 to 500. (F) DMPG vesicles alone.
(E) DMPG in the presence of peptide p2 at a peptide molar ratio of 0.13.
(A) pH 7.0 and (B) pH 5.0.
FIG. 3. Leakage of ANTS/DPX from phospholipid vesicles induced by
the p2 peptide. The p2 peptide dissolved in DMSO (5 mg/ml) was
added to 1 ml of PS vesicles (0.14 mM) loaded with ANTS and DPX in
medium buffer adjusted at the appropriate pH. (E) pH 7; (F) pH 5; (*),
DMSO alone. The mixtures were incubated at 37°C for 1 h and the
fluorescence intensity was measured at 520 nm. Maximal fluorescence
was obtained upon addition of 0.5% Triton X-100. The results shown are
representative of those obtained for three different experiments.
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p2 peptide molecule prevents an average of 15–17 phos-
pholipid molecules from undergoing the phase transi-
tion.
CD studies of peptide conformation
Figure 6 shows the CD spectra of the p2 peptide both
at pH 7.0 (A) and 5.0 (B) in the absence and in the
presence of PS vesicles. At pH 7.0 the spectrum shows a
minimum at 220 nm, which is characteristic of b-sheet
extended conformation (Perczel et al., 1992). Lowering
the pH value to 5.0 modifies the spectrum in such a way
that a minimum at 200 nm and a shoulder at 220 nm are
observed. These features are indicative of the presence
of both nonordered conformations and b-sheet. Decon-
volution of these spectra by the CCA method (Perctzel et
al., 199l) renders the data shown in Table 2. At pH 7.0,
b-sheet is the major component (66%) and at pH 5.0 the
percentage of this conformation is lower (28%). The con-
formational features observed for the p2 peptide alone
should be primarily those of the p2 peptide in monomeric
form because of the low peptide concentration used in
these studies and the fact that the solution are not turbid
cloudy but translucent.
The presence of PS vesicles induces a p2 peptide
spectrum with a minimum at around 220 nm and a
maximum at 200 nm, very similar both at pH 7.0 and 5.0.
Hence, the presence of the PS vesicles increases the
proportion of b-sheet conformation on the p2 peptide. At
pH 7.0 the increase in b-sheet is lower (from 66 to 71%)
than at pH 5.0, where the latter conformation is practi-
cally the only one observed (91%) (Table 2). Decreasing
the peptide/lipid molar ratio from 0.05 to 0.025 does not
modify the spectrum any further (not shown). Also, a
displacement of the position of the minimum, from 221 in
the absence of PS to 224–225 in the presence of PS, was
observed. This displacement could be due to a change in
the polarity of the local environment of the b-sheet
adopted.
The existence of extended conformations was further
confirmed by Fourier transform infrared spectroscopy.
However, due to the high peptide concentration used in
this technique (1.6–3.2 mM) large aggregates were
formed and the high intensity of the band at 1617 cm21
characteristic of such aggregates masked the rest of the
minor conformations, thus preventing the carrying out of
a detailed study by this means (not shown).
DISCUSSION
Because we have previously shown that a 27-aa pep-
tide (p2) from the glycoprotein G of VHS rhabdovirus
binds anionic phospholipids in solid (Estepa and Coll,
1996a,b) as well as in liquid phases (Coll, 1997) and
FIG. 6. Circular dichroism (CD) spectra of the p2 peptide incubated
with PS vesicles. The p2 peptide in medium buffer at pH 7.0 (A) and 5.0
(B) was incubated with PS vesicles for 1 h at 37°C. F, p2 peptide in the
absence of lipid. E, p2 peptide in the presence of PS at a peptide/lipid
molar ratio of 0.05.
FIG. 5. Differential scanning calorimetry (DSC) of p2 peptide mixed
with DMPG. Hydrated vesicles of DMPG containing different molar
ratios DMPG:p2 peptide were heated from 10° to 40°C and thermo-
grams recorded. The insert shows the changes in the transition en-
thalpies versus the peptide/lipid molar ratios.
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anti-p2 antibodies inhibited VHSV-induced fusion (Es-
tepa and Coll, 1997) and PS binding to VHSV at low pH
(Estepa and Coll, 1996a), we have further studied the
interaction between the p2 peptide and anionic phos-
pholipid vesicles, a model target that contains a nega-
tively charged surface and a hydrophobic bilayer. Our
expectations are that by exploring in detail the interac-
tion of the viral synthetic peptides with such a model
target, we might be able to infer the occurrence of similar
molecular events involved in the rhabdoviral–cellular
membrane first steps that lead to rhabdoviral–cellular
fusion. The p2 peptide turns out to do far more than
simply bind, it promotes vesicle aggregation, leakage,
and lipid exchange. It penetrates the lipid bilayer, as
shown by its effect on lipid phase transitions, and CD
measurements report a b-sheet conformation, stabilized
by interaction with anionic lipids.
The p2 peptide was able to induce lipid vesicle aggre-
gation, lipid mixing, and rapid leakage of lipid vesicle-
trapped fluorescent probes in a peptide concentration-
dependent manner. The vesicle–vesicle interactions that
lead to the appearance of vesicle aggregates did not
take place with neutral phospholipids, indicating the
specificity of the peptide–phospholipid interaction and
therefore the importance of its electrostatic components.
The above-mentioned results confirm previous evidence
obtained from solid-phase assays (Estepa and Coll,
1996b) that showed that PS–p2 binding occurs because
of both hydrophobic and ionic interactions, a result also
demonstrated for phospholipid–glycoprotein G interac-
tions in other rhabdoviruses (Yamada and Ohnishi, 1986).
Lipid vesicle aggregation, lipid mixing to a lesser extent,
but not lipid vesicle leakage increased at low pH, sug-
gesting that the lipid vesicle aggregation, which has to
occur first to allow lipid mixing, could be the major step
that is favored by the low-pH requirement for fusion.
Both fluorescence depolarization and DSC studies
demonstrate that the p2 peptide inserts into the hydro-
phobic core of the anionic phospholipid bilayer. Both at
pH 7.0 and at pH 5.0, the CD studies indicate that the
b-sheet conformation is practically the only one ob-
served upon interaction with PS. In this regard there is
increasing evidence that a b-sheet conformation of fu-
sion-related peptides could also be involved in the fusion
events mediated by other viruses. Thus, a human immu-
nodeficiency virus (HIV) peptide (Nieva et al., 1994) or the
fusion peptide of measles virus (Epand et al., 1992) adopt
a b-sheet structure under conditions supporting fusion or
when interacting with liposomes. On the contrary, syn-
thetic peptides containing heptad repeats contiguous to
the fusion peptide of the HIV-gp41 have been shown to
form an a-helix characteristic of a coiled coil under
physiological conditions (Wild et al., 1992), while in the
influenza virus hemagglutinin (HA) the a-helix conforma-
tion of a similar stretch of protein was pH dependent
(Bullough et al., 1994; Carr and Kim, 1993). Since com-
puter programs predict a putative a-helix inside the p2
peptide, it is possible that the p2 peptide would be in an
a-helix conformation in the native glycoprotein G. Ac-
cording to the data obtained with the synthetic p2 pep-
tide, the p2 region in the glycoprotein G could acquire a
b-sheet structure when interacting with the anionic
phospholipids. A conformational change in the glycopro-
tein G of VHSV when exposed to low-pH seems to be
occurring because the binding of anti-p2 antibodies with
purified VHSV occurs only at low pH (Estepa and Coll,
1996a). Moreover, similar low-pH-induced conforma-
tional changes in the glycoprotein G of rabies and VSV
have also been reported (Gaudin et al., 1993). Indepen-
dently of a possible previous viral–cellular receptor-me-
diated specific binding, the PS–p2 interaction studied
here could, most probably, start only after internalization
of the virus. Thus, only after internalization could the
lowering of the pH trigger the conformational changes in
glycoprotein G (Gaudin et al., 1993), which could expose
the p2 peptide to increase the interaction of viral and
cellular membranes to favor subsequent steps that will
provoke membrane destabilization. Whether the so-
called fusion peptide is carried over by the putative
low-pH-triggered p2 peptide to interact with other mem-
brane phospholipids or whether the p2 region is pulled
into the membrane by the fusion peptide is not known.
On the other hand and since the p2 peptide is behaving
exactly like the fusion peptides of influenza HA and gp41,
it could, therefore, likely play a similar role in VHSV
fusion. More experimental evidence is needed to decide
among these possibilities.
Although a peptide corresponding to part of the well-
characterized coiled-coil from the proteolytically acti-
vated influenza HA subunit binds to lipid vesicles (Yu et
al., 1994), this is not accepted as being biologically rel-
evant to fusion or infection. This is because the low-pH
form of HA lacking the fusion peptide does not bind to
lipid vesicles (Chen et al., 1995) and whereas the fusion
peptide of HA becomes photolabeled at low pH, the
coiled-coil region was not (Durrer et al., 1996). However,
this might be different for the glycoprotein G from rhab-
doviruses, which is not known to be proteolytically acti-
vated before fusion, and both the fusion putative peptide
and the heptad-repeat regions become photolabeled at
low pH when virus is incubated with liposomes (Durrer et
al., 1995; Gaudin et al., 1995a). Interactions of the regions
containing heptad repeats with phospholipids have also
been demonstrated in HIV-gp41 by membrane-binding
studies (Rabenstein and Shin, 1995) and in the rhabdovi-
ruses VHSV (Estepa and Coll, 1996a,b), VSV, and rabies
(Coll, 1997) by solid-phase and liquid-phase binding as-
says. Mutations in the hydrophobic aa of the heptad
repeats of the glycoproteins of several paramyxoviruses
(Rapaport et al., 1995; Reitter et al., 1995; Sergel-Ger-
mano et al., 1994), baculovirus (Monsma and Blissard,
1995), HIV (Wild et al., 1994) and murine leukemia virus
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(Ramsdale et al., 1996) abolished viral fusion. Thus, all
the above-mentioned results suggest that not only the
fusion peptide but also adjacent downstream heptad
repeats might be important for fusion (Reitter et al., 1995),
at least in some viruses.
In conclusion, the p2 peptide corresponding to the
amino-terminal heptad repeat and positively charged
head of glycoprotein G of VHSV has been shown to
induce aggregation of lipid vesicles, close apposition of
membranes, and destabilization of anionic phospholipid
bilayers, most of the essential steps required for fusion
(Bentz et al., 1983). Although there is not yet evidence
that the interaction being studied here is really relevant
to VHSV entry, these findings and the fact that anti-p2
antibodies inhibited fusion (Estepa and Coll, 1997) and
PS binding to VHSV (Estepa and Coll, 1996a) support the
idea that this region of the G protein might play an active
role in the viral fusogenic processes and that it might be
considered an important target for the design of strate-
gies for the prevention of VHSV infection in vivo.
METHODS
Reagents
Bovine brain phosphatidylserine (PS), egg phospha-
tidylcholine (PC), 1,2-dimyristoilphosphatidylglycerol
(DMPG), N-(7-nitro-2,1,3-benzoxadiazol-4-yl)dimyristoylphos-
phatidylethanolamine (NBD-PE), and N-(lissamine rhoda-
mine B sulfonyl)-diacylphosphatidylethanolamine (RH-
PE) were provided by Avanti Polar Lipids (Alabaster, AL).
1,6-Diphenyl-1,3,5-hexatriene (DPH) was obtained from
Aldrich. 8-Aminonaphtalene-1,3,6-trisulfonic acid (ANTS)
and p-xylenebis (pyridium) bromide (DPX) were obtained
from Molecular Probes. Triton X-100 was purchased from
Boehringer Mannheim (Penzberg, Germany).
Peptide synthesis
The 27-amino-acid (aa) peptide covering the major
amino-terminal PS-binding region of the glycoprotein G
of VHSV with the sequence: 82IIPHLPLSVTSVSAVAS-
GHYLHRVTYRVT109 (Table 1) was synthesized (Clontech,
Palo Alto, CA). Due to the low solubility of the peptide in
aqueous buffers, a 5 mg/ml stock solution of the peptide
in dimethyl sulfoxide (DMSO) or trifluoroethanol (TFE)
was kept at 220°C and employed in the various assays.
The final organic solvent concentration was kept under
1.5% (v/v) in all the assays since it had no measurable
effect on lipid vesicle stability.
Lipid vesicle preparation
A phospholipid film was obtained upon overnight dry-
ing of a chloroform solution under vacuum. The phos-
pholipids were resuspended at a concentration of 1
mg/ml in medium buffer (100 mM NaCl, 5 mM MES, 5
mM sodium citrate, 5 mM Tris, 1 mM EDTA) at the
appropriate pH value for 1 h at 37°C and vortexed vig-
orously. This suspension was subjected to 19 cycles of
extrusion in a LoposoFast Basic extrusion apparatus
with 100-nm polycarbonate filters (Avestin Inc.). When
encapsulation was necessary, an additional step of four
freeze–thawing cycles was included after the hydration
process (see below). A 0.14 mM phospholipid final con-
centration was used in all the experiments.
Vesicle aggregation assay
The optical density (OD) variation at 360 nm produced
by the addition of the p2 peptide from the DMSO stock
solution to a phospholipid vesicle suspension in medium
buffer at the appropriate pH was measured on a Beck-
TABLE 1
Position of the p2 Peptide in the G Sequence of VHSV
..RPAQLRCPHEFEDINKGLVSVPTRIIHLPLSVTSVSAVASGHYLHRVTYRVTC... G
IIHLPLSVTSVSAVASGHYLH a-helix
IIHLPLSVTSVSAVASGHYLHRVTYRVT P2
¦ ¦ ¦ ¦ ¦ ¦ ¦ ¦ ¦ ¦ ¦ ¦
55 60 65 70 75 80 85 90 95 100 105 110
Note. G, partial sequence of the G gene from VHSV 07.71 (Thiry et al., 1991b). a-Helix, putative a-helix predicted by the HELIXMEM program from
the PCGene package. p2, designed synthetic peptide containing the putative a-helix plus the 2 Arg (R) containing carboxy-terminal sequence
(RVTYRVT) called ‘‘head.’’ This sequence (aa 82–109) was shown to contain the major binding domain of the glycoprotein G of the VHSV (Coll, 1997;
Estepa and Coll, 1996a; Estepa and Coll, 1996b). The region containing only heptad repeats (aa 68–99) is not predicted to form coiled-coils by the
algorithm of Lupas (Coll, 1995b; Lupas et al., 1991). The hydrophobic aa of the a–d hydrophobic heptad repeats are in bold. Numbers are the
amino-terminal aa positions on glycoprotein G by including the signal peptide.
TABLE 2
Secondary Structure of the p2 Peptide from CD Data
pH 7.0 pH 5.0
p2 p2 1 PS p2 p2 1 PS
b-Sheet 66 71 28 91
b-Turn 16 17 43 1
Nonordered 18 12 31 8
Note. Data are expressed as percentages.
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man DU-7 spectrophotometer after 1 h incubation at
37°C. To account for the absorbance of phospholipid
vesicles and peptide alone, control samples containing
equal amounts of DMSO, but in the absence of peptide
or phospholipid, were included.
Lipid vesicles mixing assay
The p2-induced decrease in the efficiency of the fluo-
rescence energy transfer due to dilution between
NBD-PE (energy donor) and RH-PE (energy acceptor)
incorporated into lipid vesicles as a consequence of lipid
mixing was measured (Struck et al., 1981). Lipid vesicles,
in medium buffer at the appropriate pH, labeled with 1
mol% NBD-PE and 0.6 mol% RH-PE were mixed with
unlabeled lipid vesicles in a 1:9 molar ratio. The assay
was initiated by addition of the p2 peptide from the
DMSO stock solution. The samples were incubated for
1 h at 37°C and the emission spectra were recorded in
a SLM Amino 8000 spectrofluorimeter at an excitation
wavelength of 450 nm. Both the excitation and emission
slits were set at 4 nm. The excitation and emission
polarizers were kept constant at 90° and 0°, respectively,
to minimize dispersive interference. The efficiency of the
energy transfer was calculated from the ratio of the
emission intensities at 530 and 585 nm and the appro-
priate calibration curve.
Leakage assay
Leakage of vesicles was determined by the ANTS/DPX
assay (Ellens et al., 1985), based on the dequenching of
ANTS fluorescence caused by its dilution upon release
of the aqueous contents of lipid vesicle containing both
ANTS and DPX. It was performed coencapsulating 12.5
mM ANTS and 45 mM DPX in 20 mM NaCl, 10 mM Tris,
pH 7.2, into PS vesicles. PS was first hydrated for 1 h at
37°C, and then the PS vesicles were subjected to four
cycles of freeze–thawing in liquid nitrogen and passed
through a LiposoFast Basic extrusion apparatus at least
19 times with 100-nm polycarbonate filters (Avestin, Inc.).
The sample was passed through a Sephadex G-75 col-
umn (Pharmacia) in the above-mentioned buffer to sep-
arate the PS vesicles from the nonencapsulated material
(Duzgunes and Shavnin, 1992). Leakage was initiated by
addition of the p2 peptide from the DMSO stock solution.
The samples were incubated for 1 h at 37°C. The sus-
pensions were excited at 385 nm and ANTS emission
was monitored at 520 nm. Both the excitation and emis-
sion slits were set at 4 nm. The excitation polarizer was
kept constant at 90° and the emission polarizer was kept
constant at 0° to minimize dispersive interference. The
fluorescence scale was set to 100% by addition of 0.5%
Triton X-100 and the 0% leakage was obtained by mea-
suring the fluorescence of the control vesicles after the
addition of DMSO.
Fluorescence polarization
Fluorescence polarization measurements of DPH
were made on a SLM Aminco 8000C spectrofluorimeter
equipped with 10-mm Glan-Thompson polarizers. DMPG
(0.14 mM) containing DPH at a ratio of 1 molecule of DPH
for every 500 DMPG molecules was hydrated at the
appropriate pH and extruded as indicated above. The
peptide was added from the DMSO stock solution and
the peptide–vesicle mixtures were incubated for 1 h at
37°C and then cooled down. The excitation wavelength
was set at 365 nm and the emission was measured at
425 nm after equilibration of the samples at the required
temperature. The temperature in the cuvette was main-
tained with a Polystat Huber circulating water bath.
Differential scanning calorimetry (DSC)
Large multilamellar vesicles made from synthetic
DMPG were used for the calorimetric measurements.
Dried lipid films were suspended in medium buffer at pH
5.0 to give a final concentration of 1.5 mM in terms of lipid
phosphorus. The suspended lipids were kept for 90 min
above their phase transition temperature and vortexed.
The resulting liposomes were stored overnight at 4°C, to
assure a complete hydration of the sample prior to the
DSC measurements. Thermograms were recorded on a
high-resolution Microcal MC-2 differential scanning mi-
crocalorimeter, equipped with the DA-2 digital interface
and a data acquisition utility for automatic data collection
as described earlier (Villar et al., 1988). The lipid disper-
sions containing added p2 peptide at different molar
ratios and the corresponding buffer in the reference cell
were thermally equilibrated in the microcalorimeter at ;
10°C for 45 min before heat was applied. Differences in
the heat capacity between the sample and the reference
cell were obtained by raising the temperature at a con-
stant rate of 45°C/h. Transition temperatures and enthal-
pies were calculated by fitting the observed transitions to
a single van‘t Hoff component. Reported transition tem-
peratures correspond to those at which there is a max-
imum differential heat capacity as observed in the ther-
mograms.
Circular dichroism (CD)
Aliquots of the p2 peptide from a stock solution at 5
mg/ml in trifluoroethanol (TFE) were added to medium
buffer (100 mM NaCl, 5 mM Tris, 5 mM citrate, 5 mM
MES, 1 mM EDTA) at the appropriate pH to give a final
concentration of the peptide of 32.5 mM. The peptide was
dissolved in TFE because the high absorbance of DMSO
precludes its use in CD. The effect of the interaction with
PS vesicles on the p2 conformation was determined by
adding increasing amounts of PS to peptide aliquots. The
mixtures were allowed to react for 1 h at 37°C and then
were subjected to bath sonication. The clear sonicated
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solutions were then analyzed by CD. The CD spectra
were recorded on a JASCO 715 dichrograph at 25°C and
with a 1-mm pathlength cell at a scanning speed of 0.5
nm/s. The temperature in the cuvette was maintained
with a Neslab RTE-111 circulating water bath. A minimum
of four spectra were accumulated for each sample. The
peptide concentration was determined by amino acid
analysis on a Beckman 6300 automatic amino acid an-
alyzer. Deconvolution of the CD data was performed
according to the convex constraint analysis method (Per-
czel et al., 1991). This method relies on an algorithm that
calculates the contribution of the secondary structure
elements that give rise to the original spectral curve
without referring to spectra from model systems. This
analysis provides evidence that the CD spectrum of a
protein contains independent information of at least four
different additive secondary structures.
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